Our approach

 
 

We work at the heart of what matters.

It comes down to relevance, meaning and purpose.

Healthcare is in a state of flux. Higher expectations for real-world outcomes, a noisy digital media environment, financial pressure to do more with less. This is the new normal for the healthcare industry, and it means it’s time to reimagine marketing. It’s time to redesign how we best engage providers and patients. It’s time to focus on what really matters.

closerlook is a new type of lead agency, bringing a novel approach to biopharma marketing. We are obsessed with relevance, committed to what’s truly meaningful and driven to make a positive difference in the world. We fuse insight, strategy, creative and technology to help brands achieve what matters most—the combination of better patient outcomes and bigger business impact.

 


Our ongoing endeavor of empathy

In order to achieve relevance and engage customers meaningfully, we must first understand them as real people—not just as patients or physicians or nurses or caregivers. And that commitment to understanding is a continuous effort. People change. And so should our understanding of them. We call this the “ongoing endeavor of empathy,” and it informs everything we do from start to finish to start again.

We also believe this endeavor must extend to everyone we work with—especially our clients. Ensuring that we do our best to truly hear our clients—both in what they say and what they don’t say—enables us to make smarter, better recommendations that can become reality more quickly. The benefit is better work in the real world, engaging the right customers, more meaningfully, more often.

How We Work


Powered by Agility

At closerlook, we have adopted an agile approach to work because it enables our teams to focus on creating more relevant, more meaningful, more effective work more quickly. The productive cycle of learning and acting allows for smarter strategy, more compelling creative, more timely optimizations and a successful navigation of inevitable change.


Agility: A source of competitive advantage

Agility powers our ability to outpace a brand’s competition. Adopting an iterative approach to learning, thinking, planning and acting enables us to create competitive advantage. These cycles of learning, doing and improving accelerate development by maintaining a shared focus on the heart of what matters. We avoid the fruitless search for evasive consensus; we focus on the critical alignment between customers and a brand’s strategy. The ability to both understand what customers need faster than a brand’s competition and then act on that insight remains the best—and only real—source of competitive advantage.


Agility: A method for navigating uncertainty and change

Agility also allows for the proactive prioritization of effort so that we can be productive in the face of uncertainty—the one constant in any innovative, meaningful marketing effort. We can always re-prioritize in constructive ways as the facts of the situation inevitably change during the process while preserving our focus on what matters most—customers’ needs and business impact.


Agility: A method for innovation

Agile methods prize regular collaborative interactions with customers and stakeholders to proactively solicit input about what is most important to them. These ongoing interactions fuel development by maintaining a shared focus on what matters most. Our product and service offerings demonstrate “proof of life” early in the process—or not. The ideas that prove valuable then are developed, enhanced and refined iteratively with more interaction with customers. The output is meaningful innovation that addresses real customers' real needs and creates real value for brands.

The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.

Let’s start the conversation. Contact us